SCHEMBL17355017

SCHEMBL17355017

CCC1CCC(C2CCC(C3CCC(OC)C(F)C3F)CC2F)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10016794 0.91 — —
SCHEMBL17620777 0.90 — —
SCHEMBL17355020 0.89 — —
SCHEMBL17355021 0.87 — —
SCHEMBL17355004 0.87 CYP1A2 (0.33) —
SCHEMBL17355024 0.85 — —
SCHEMBL17355023 0.85 — —
SCHEMBL17355036 0.84 — —
SCHEMBL16789880 0.84 — —
SCHEMBL17355018 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180030350-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2018-02-01 — — US disclosed
US-20170044438-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2017-02-16 — — US disclosed
US-20170044438-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2017-02-16 — — US disclosed
EP-2957618-A1 LIQUID CRYSTALLINE MEDIUM Merck Patent GmbH (DE) 2015-12-23 — — EP disclosed
Send feedback